Partner Therapeutics, Inc.
Partner Therapeutics, Inc. received $50.2M in federal prime contract obligations in the 12 months ending Oct 5, 2026, up 28.4% from $39.1M the year before, and $206.5M since FY2022. Its largest customer is the Department of Health and Human Services.
See 2 contracts ending in the next 18 months ↓Contractor details
- Unique Entity ID (UEI)
- J33MSDBJZMC6
- CAGE code
- 7ZTL0
- Headquarters
- Lexington, MA
- Business size
- Small Business
As recorded on this UEI's most recent prime contract action in USAspending.gov. Confirm current registration and certifications in SAM.gov.
Obligations by fiscal year
Net prime contract obligations by federal fiscal year.
Markets where it ranks top 10
Agency and NAICS markets where this UEI is one of the ten largest primes in the latest 12 months.
Top agencies
Funding agencies ranked by obligations since FY2022.
| Funding agency | Latest 12 mo | Since FY2022 |
|---|---|---|
| Department of Health and Human Services | $50.0M | $206.3M |
| Department of Veterans Affairs | $235K | $235K |
Top NAICS codes
Industry codes agencies recorded on this contractor's awards, since FY2022.
| NAICS | Industry | Latest 12 mo | Since FY2022 |
|---|---|---|---|
| 325412 | Pharmaceutical Preparation Manufacturing | $50.2M | $192.8M |
| 541715 | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | $0 | $13.0M |
| 541714 | Research and Development in Biotechnology (except Nanobiotechnology) | $0 | $748K |
What it sells
Product and service codes (PSC) on this contractor's awards, since FY2022.
| PSC | Description | Since FY2022 |
|---|---|---|
| 6515 | Medical and Surgical Instruments, Equipment, and Supplies | $133.5M |
| 6505 | Drugs and Biologicals | $59.3M |
| AN13 | Health R&D services; Health Care services; Experimental Development | $13.0M |
| AN15 | Health R&D services; Health Care services; Expenses for R&D Facilities and Major Equipment | $748K |
Contracts ending in the next 18 months
This contractor's largest awards whose current period of performance ends soon. Options and extensions often move these dates.
| Award | Agency | Obligated | Current end |
|---|---|---|---|
| 75A50323F80027 | Department of Health and Human Services LEUKINE 250MCG VIL INJ (5PKG) | $133.5M | Mar 29, 2027 |
| 75A50124C00061 | Department of Health and Human Services PARTNER THERAPEUTICS: THE OVERALL OBJECTIVE OF THIS CONTRACT IS TO CONFIRM LEUKINE SAFETY IN SEPSIS PATIENTS, INFORM OPTIMAL LEUKINE DOSING, EXPLORE LEUKINE EFFICACY, AS WELL AS… | $13.0M | Mar 31, 2028 |
Recent awards
This contractor's newest prime contract awards, most recent first.
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| 36C24626N1034 | Department of Veterans Affairs BIZENGRI MEDICATION | $72K | Sep 4, 2026 |
| 36C24626N0782 | Department of Veterans Affairs EMERG. BIZENGRI MEDS FOR VETERAN | $73K | Jun 16, 2026 |
| 36C24626N0690 | Department of Veterans Affairs EMERGENCY BIZENGRI MEDS. FOR VETERAN | $54K | May 5, 2026 |
| 36C24626N0637 | Department of Veterans Affairs EMERGENCY BIZENGRI MEDS FOR VETERAN | $36K | Apr 10, 2026 |
| 75A50124C00061 | Department of Health and Human Services PARTNER THERAPEUTICS: THE OVERALL OBJECTIVE OF THIS CONTRACT IS TO CONFIRM LEUKINE SAFETY IN SEPSIS PATIENTS, INFORM OPTIMAL LEUKINE DOSING, EXPLORE LEUKINE EFFICACY, AS WELL AS… | $13.0M | Sep 24, 2024 |
| 75A50323F80027 | Department of Health and Human Services LEUKINE 250MCG VIL INJ (5PKG) | $22.2M | Sep 26, 2023 |
| 75A50123C00064 | Department of Health and Human Services R&D FOR REPURPOSING FX06, A HOST-DIRECTED THERAPY, FOR TREATMENT OF SEVERE DISEASE IN PATIENTS WITH SUDAN VIRUS DISEASE (SVD) OR OTHER FILOVIRUSES AOI #22 REBOOT | $748K | Sep 25, 2023 |
| 75A50322F80018 | Department of Health and Human Services LEUKINE 250MCG/VIL INJ | $59.0M | Jul 25, 2022 |
Prime contracts (award types A–D) from USAspending.gov through Oct 5, 2026. Subcontracts are not included. Net obligations include deobligations and corrections.
Ready to connect your pursuit work?
GovEagle gives BD directors, capture managers, and proposal teams one AI workspace from pipeline through proposal, with CMMC/FedRAMP Certified compliance built in.